Pharm@dvice: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Pharm@dvice
Largest movements
- Receivables within one year +€51,273
up €51,273 (+48.9%), from €104,959 to €156,232
of which Trade receivables: +€54,886
- Cash -€42,585
down €42,585 (-79.6%), from €53,485 to €10,900
mainly Receivables within one year (-€51,273) and Other debts (-€44,332)
- Tangible fixed assets -€22,870
down €22,870 (-9.4%), from €242,076 to €219,207
of which Plant, machinery and equipment: -€13,797
- Stocks and contracts +€9,266
up €9,266 (+5.3%), from €173,492 to €182,758
- Trade debts +€46,807
up €46,807 (+49.8%), from €93,950 to €140,757
- Other debts -€44,332
down €44,332 (-53.3%), from €83,230 to €38,898
- Debts after one year -€38,977
down €38,977 (-12.4%), from €313,510 to €274,532
- Reserves +€36,000
up €36,000 (+1,935%), from €1,860 to €37,860
- Profit (loss) carried forward -€29,250
down €29,250 (-98.2%), from €29,787 to €537
- Gross operating margin +€22,298
up €22,298 (+36.0%), from €61,925 to €84,222
- Other operating charges -€2,575
down €2,575 (-49.4%), from €5,213 to €2,638
- Financial charges -€2,094
down €2,094 (-13.8%), from €15,123 to €13,030
- Taxes -€954
down €954 (-24.9%), from €3,840 to €2,886
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €577,183 | €571,791 | -€5,392 | -0.9% |
| Formation expenses | 20 | €174 | - | -€174 | |
| Fixed assets | 21/28 | €242,076 | €219,207 | -€22,870 | -9.4% |
| Tangible fixed assets | 22/27 | €242,076 | €219,207 | -€22,870 | -9.4% |
| Land and buildings | 22 | €151,084 | €139,932 | -€11,152 | -7.4% |
| Plant, machinery and equipment | 23 | €82,520 | €68,723 | -€13,797 | -16.7% |
| Furniture and vehicles | 24 | €7,572 | €9,652 | +€2,079 | +27.5% |
| Assets under construction and advance payments | 27 | €900 | €900 | = | 0.0% |
| Current assets | 29/58 | €334,933 | €352,585 | +€17,652 | +5.3% |
| Stocks and contracts in progress | 3 | €173,492 | €182,758 | +€9,266 | +5.3% |
| Stocks | 30/36 | €173,492 | €182,758 | +€9,266 | +5.3% |
| Amounts receivable within one year | 40/41 | €104,959 | €156,232 | +€51,273 | +48.9% |
| Trade receivables | 40 | €96,210 | €151,096 | +€54,886 | +57.0% |
| Other amounts receivable | 41 | €8,749 | €5,135 | -€3,613 | -41.3% |
| Cash at bank and in hand | 54/58 | €53,485 | €10,900 | -€42,585 | -79.6% |
| Deferred charges and accrued income | 490/1 | €2,996 | €2,694 | -€302 | -10.1% |
| Total equity and liabilities | 10/49 | €577,183 | €571,791 | -€5,392 | -0.9% |
| Equity | 10/15 | €44,047 | €50,797 | +€6,750 | +15.3% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,860 | €37,860 | +€36,000 | +1,935% |
| Distributable reserves | 133 | €1,860 | €37,860 | +€36,000 | +1,935% |
| Profit (loss) carried forward | 14 | €29,787 | €537 | -€29,250 | -98.2% |
| Amounts payable | 17/49 | €533,137 | €520,994 | -€12,142 | -2.3% |
| Amounts payable after more than one year | 17 | €313,510 | €274,532 | -€38,977 | -12.4% |
| Financial debts | 170/4 | €313,510 | €274,532 | -€38,977 | -12.4% |
| Amounts payable within one year | 42/48 | €219,529 | €246,206 | +€26,676 | +12.2% |
| Current portion of amounts payable after more than one year | 42 | €38,239 | €38,977 | +€738 | +1.9% |
| Financial debts | 43 | - | €20,492 | +€20,492 | |
| Credit institutions | 430/8 | - | €20,492 | +€20,492 | |
| Trade debts | 44 | €93,950 | €140,757 | +€46,807 | +49.8% |
| Suppliers | 440/4 | €93,950 | €140,757 | +€46,807 | +49.8% |
| Taxes, remuneration and social security | 45 | €4,110 | €7,081 | +€2,971 | +72.3% |
| Taxes | 450/3 | €4,110 | €7,081 | +€2,971 | +72.3% |
| Other amounts payable | 47/48 | €83,230 | €38,898 | -€44,332 | -53.3% |
| Accrued charges and deferred income | 492/3 | €98 | €257 | +€159 | +162% |
| Remuneration, social security and pensions | 62 | €177 | €180 | +€4 | +2.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28,952 | €28,746 | -€206 | -0.7% |
| Other operating charges | 640/8 | €5,213 | €2,638 | -€2,575 | -49.4% |
| Gross operating margin | 9900 | €61,925 | €84,222 | +€22,298 | +36.0% |
| Operating profit (loss) | 9901 | €27,583 | €52,658 | +€25,075 | +90.9% |
| Financial income | 75/76B | - | €8 | +€8 | |
| Recurring financial income | 75 | - | €8 | +€8 | |
| Financial charges | 65/66B | €15,123 | €13,030 | -€2,094 | -13.8% |
| Recurring financial charges | 65 | €15,123 | €13,030 | -€2,094 | -13.8% |
| Profit (loss) for the period before taxes | 9903 | €12,460 | €39,636 | +€27,176 | +218% |
| Income taxes | 67/77 | €3,840 | €2,886 | -€954 | -24.9% |
| Profit (loss) for the period | 9904 | €8,620 | €36,750 | +€28,131 | +326% |
| Profit (loss) for the period to be appropriated | 9905 | €8,620 | €36,750 | +€28,131 | +326% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.